NIHR Maudsley BRC Blog

Our latest news & events

Multi-variant vaccine study opens at King's CRF

A new vaccine study which will assess the safety and efficacy of a vaccine will will target multiple variants of the COVID-19-causing Sars-CoV-2 virus - including the current dominant variant Omicron.

By NIHR Wellcome King's Clinical Research Facility at 13 Apr 2022

New research suggests a causal link between blood group and severe COVID-19

A new study has analysed over 3000 proteins to identify which are causally linked to the development of severe COVID-19. This is the first study to assess such a large number of proteins for their connection to COVID-19. The findings provide insight into potential new targets for approaches to treat and prevent severe COVID-19.

 

By NIHR Maudsley BRC at 3 Mar 2022

Novavax COVID-19 jab trialled at King’s CRF approved by UK drugs agency

UK drugs regulator, the Medicine and Healthcare products Regulatory Agency (MHRA) has approved Novavax's Nuvaxovid vaccine, which was trialled at the King's CRF, for use in the UK.

By NIHR Wellcome King's Clinical Research Facility at 16 Feb 2022

Six years of memory decline seen in anxious, depressed older people during pandemic

Older people who were more anxious and depressed during the first year of the COVID-19 pandemic were found to have an average decline in their short term memory equivalent to six years of natural ageing.

By NIHR Maudsley BRC at 9 Nov 2021

Excess deaths in people with mental health conditions increased during the COVID-19 pandemic

The greater number of deaths amongst those with mental health conditions and intellectual disabilities has been amplified during the COVID-19 pandemic, a study based on more than 160,000 patients has revealed.

By NIHR Maudsley BRC at 8 Oct 2021